Polar Capital Holdings »

Aeglea Biotherapeutics shares owned by Polar Capital Holdings

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Polar Capital Holdings from 13F filings

Historical chart of Polar Capital Holdings investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Polar Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Polar Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.7M 300k 12.25

More positions owned by Polar Capital Holdings

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Arch Cap Group Ord (ACGL)
Amazon (AMZN)
Renaissance Re Holdings Ltd Cmn (RNR)
Chubb (CB)
Servicenow (NOW)
Marsh & McLennan Companies (MMC)
Crowdstrike Hldgs Cl A (CRWD)
Hubspot (HUBS)

View all positions for Polar Capital Holdings

Top funds holding Aeglea Biotherapeutics

FMR
Perceptive Advisors
VR Adviser
Commodore Capital
venBio Select Advisor
Adage Capital Partners GP
Franklin Resources
Citadel Advisors
Wellington Management Company
BlackRock
Braidwell
Vanguard Group
Darwin Global Management
Farallon Capital Management
First Turn Management

View all funds holding Aeglea Biotherapeutics